Navigation Links
Pharmaceutical and Biotech Executives Must Manage and Optimize Key Opinion Leaders or Fall Behind in the Marketplace
Date:6/13/2010

CHAPEL HILL, N.C., June 11 /PRNewswire/ -- Key Opinion Leaders (KOLs) possess a credibility earned through experience and their relationships in their therapeutic area. As a result, KOLs can serve as natural resources for pharmaceutical companies in terms of generating market interest and providing knowledge about specific drugs.

In the ever-changing business environment all life sciences companies face, it is crucial that executives make proper decisions in utilizing and managing the KOLs they work with.

With this in mind, Best Practices, LLC offers its newest thought leader service that provides access to hundreds of best practices in regards to KOL utilization and management. For more information on our services, click here http://www3.best-in-class.com/oe4.htm.

Executives must constantly examine their structure and processes to find improvements for working with their KOLs, and Best Practices, LLC's tools and resources have guided KOL managers for nearly two decades.

This information has been consolidated into the Thought Leadership Excellence Services, a comprehensive package that provides primary research from leading pharmaceutical and biotech companies, as well as case examples of successful practices with KOLs. This service is an essential guide to planning, implementing, and maintaining a productive Thought Leadership function. Click here for more information http://www3.best-in-class.com/oe4.htm .

This service contains a variety of data in thought leader areas from how they relate to patient advocacy to how the role they play in preparing the market for new product launches.

This service also provides valuable material for executives of the pharmaceutical organization to ensure superior development and implementation of Thought Leadership strategies. Executives will find numerous resource-related issues addressed, while implementation level managers will be able to create roadmaps and plans for accomplishing their objectives in key areas.

Among the information that can be explored through this collection:

  • Annual Membership to the Best Practice Life Sciences Database, with access to more than $35 million in benchmarking research
  • Optimizing Key Opinion Leader Relationships: Best Practices in KOL Management
  • Patient Advocacy and Professional Organizations: Building Effective Relationships
  • New Product Planning for Medical Marketing Structure and Activities to Drive Growth & Profitability
  • Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders
  • Collaborating with Patient Advocacy Groups to Educate the Marketplace

To explore the Thought Leadership Excellence Services in greater detail, download our complimentary research excerpt here http://www3.best-in-class.com/oe4.htm, or contact Cameron Tew at 919-767-9246 or via email at ctew@best-in-class.com.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. 


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
2. Syndax Pharmaceuticals Entinostat Shows Clinical Promise in Patients with Advanced Hormone Refractory Breast Cancer
3. Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
4. Jiangbo Pharmaceuticals, Inc. Receives Approval to List on the NASDAQ Global Market
5. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
6. Alexza Pharmaceuticals to Present at Jefferies 2010 Global Life Sciences Conference
7. Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals
8. Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd.
9. Jazz Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
10. Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development
11. Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Pulmatrix, Inc . (NASDAQ: PULM), a clinical stage biopharmaceutical company ... announced that it has added two experts in the fields ... Scientific Advisory Board . The two experts ... MD, former chief of the Pediatric Pulmonary and Allergy Divisions ... University, and David Denning , MD, ...
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... DUBLIN and BOSTON ... AGN), a leading global pharmaceutical company and Paratek ... on the development and commercialization of innovative therapies ... Phase 3 trials of sarecycline for the treatment ... week primary efficacy endpoints. Sarecycline is a once-daily, ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... ... -centric training, today announced the launch of a new research study, The Business ... skills needed to execute that strategy, and the actual success of achieving individual ...
(Date:3/27/2017)... ... , ... According to the American Cancer Society , the average 15-year ... Once the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year ... this latter group, tune in to Lifestyle Magazine on April 9, 2017, ...
(Date:3/27/2017)... ... 2017 , ... Golden Triangle Emergency Center will be hosting ... to commemorate the two-year anniversary of the facility. The event will feature refreshments ... years while also familiarizing themselves with the facility. , In the two years ...
(Date:3/25/2017)... ... 2017 , ... Getting earned media coverage meaningful for Garden Media Group's clients ... the year, Garden Media aims to provide material helpful to clients’ goals and bottom ... client’s key messages to gain coveted media placements, Garden Media wows clients year-round. ...
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease ... hospitals in the United States, it’s a threat that is constantly changing and ... infection prevention and offers strategies for the healthcare community to help decrease the ...
Breaking Medicine News(10 mins):